Skip to main content

Table 1 Source and description of commercial E 2 kits used to measure E 2 following aromatase inhibitor treatment

From: Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients

Company

Kit

Type of Assay

Sensitivity reported by manufacturer

Lowest E2Concentration on Standard Curve in our study*

Siemens Healthcare Diagnostics (Plainfield, IL)

Immulite 2000 Estradiol

Automated Direct Chemiluminescent Immunoassay

20

20

Siemens Healthcare Diagnostics (Plainfield, IL)

Coat-A-Count Estradiol RIA

Manual Direct RIA on coated Tube

8

20

Siemens Healthcare Diagnostics (Plainfield, IL)

Double Antibody Estradiol RIA

Manual Direct RIA

1.4

5

Beckman Coulter (Brea, CA)

Ultra-Sensitive Estradiol RIA

Manual Direct RIA

2.2

5

Roche Diagnostics (Indianapolis, IN)

Elecsys 2010 Estradiol II

Automated Direct Electro-chemiluminescent Immunoassay

5

5

Pantex Santa Monica, CA)

Extraction 125I Estradiol RIA

RIA with preceding extraction Step

10

10

  1. * represents sensitivity of the evaluated assay.